Ctt Pharmaceutical Holdings annual total liabilities
2010
2011
2012
2013
2014
2024
2025
Ctt Pharmaceutical Holdings Total Liabilities Growth & History (CTTH)
Ctt Pharmaceutical Holdings's total liabilities was $31,018 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31,018 | −$9,841 | −24.09% |
| 2024 | 2024-12-31 | $40,859 | — | — |
| 2014 | 2014-12-31 | $169,490 | $133,916 | +376.44% |
| 2013 | 2013-12-31 | $35,574 | −$553,839 | −93.96% |
| 2012 | 2012-12-31 | $589,413 | −$3.1M | −84.18% |
| 2011 | 2011-12-31 | $3.7M | $2.5M | +195.54% |
| 2010 | 2010-12-31 | $1.3M | — | — |
Ctt Pharmaceutical Holdings quarterly total liabilities
Q4.10
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $41,391 | $21,362 | +106.66% |
| Q1 2026 | 2026-03-31 | $34,918 | — | — |
| Q4 2025 | 2025-12-31 | $31,018 | −$9,841 | −24.09% |
| Q3 2025 | 2025-09-30 | $21,043 | — | — |
| Q2 2025 | 2025-06-30 | $20,029 | — | — |
| Q4 2024 | 2024-12-31 | $40,859 | — | — |
| Q3 2015 | 2015-09-30 | $183,960 | $59,360 | +47.64% |
| Q2 2015 | 2015-06-30 | $156,373 | $14,386 | +10.13% |
| Q1 2015 | 2015-03-31 | $211,696 | −$68,172 | −24.36% |
| Q4 2014 | 2014-12-31 | $169,490 | $133,916 | +376.44% |
| Q3 2014 | 2014-09-30 | $124,600 | −$372,458 | −74.93% |
| Q2 2014 | 2014-06-30 | $141,987 | −$348,535 | −71.05% |
| Q1 2014 | 2014-03-31 | $279,868 | −$183,274 | −39.57% |
| Q4 2013 | 2013-12-31 | $35,574 | −$553,839 | −93.96% |
| Q3 2013 | 2013-09-30 | $497,058 | −$80,023 | −13.87% |
| Q2 2013 | 2013-06-30 | $490,522 | −$83,123 | −14.49% |
| Q1 2013 | 2013-03-31 | $463,142 | −$98,495 | −17.54% |
| Q4 2012 | 2012-12-31 | $589,413 | −$3.1M | −84.18% |
| Q3 2012 | 2012-09-30 | $577,081 | $238,976 | +70.68% |
| Q2 2012 | 2012-06-30 | $573,645 | $97,780 | +20.55% |
| Q1 2012 | 2012-03-31 | $561,637 | — | — |
| Q4 2011 | 2011-12-31 | $3.7M | $2.5M | +195.54% |
| Q3 2011 | 2011-09-30 | $338,105 | — | — |
| Q2 2011 | 2011-06-30 | $475,865 | — | — |
| Q4 2010 | 2010-12-31 | $1.3M | — | — |
Ctt Pharmaceutical Holdings total liabilities trends
Between the periods ended 2010-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's total liabilities decreased from $1.3M to $31,018, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $41,391.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗